Kornitzer Capital Management Inc. KS cut its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 7.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 61,272 shares of the medical research company's stock after selling 4,992 shares during the period. Kornitzer Capital Management Inc. KS's holdings in Agilent Technologies were worth $9,098,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Norden Group LLC bought a new position in shares of Agilent Technologies in the first quarter valued at $342,000. Larson Financial Group LLC grew its stake in shares of Agilent Technologies by 29,300.0% in the first quarter. Larson Financial Group LLC now owns 294 shares of the medical research company's stock valued at $43,000 after buying an additional 293 shares in the last quarter. Texas Permanent School Fund Corp grew its stake in shares of Agilent Technologies by 0.3% in the first quarter. Texas Permanent School Fund Corp now owns 60,579 shares of the medical research company's stock valued at $8,815,000 after buying an additional 164 shares in the last quarter. Manchester Capital Management LLC grew its stake in shares of Agilent Technologies by 425.6% in the first quarter. Manchester Capital Management LLC now owns 883 shares of the medical research company's stock valued at $128,000 after buying an additional 715 shares in the last quarter. Finally, Empirical Finance LLC grew its stake in shares of Agilent Technologies by 3.4% in the first quarter. Empirical Finance LLC now owns 10,865 shares of the medical research company's stock valued at $1,581,000 after buying an additional 359 shares in the last quarter.
Agilent Technologies Trading Down 2.1 %
Shares of NYSE:A traded down $2.95 during midday trading on Friday, hitting $136.68. 1,918,629 shares of the stock were exchanged, compared to its average volume of 1,688,442. The stock has a market capitalization of $39.27 billion, a price-to-earnings ratio of 28.97, a P/E/G ratio of 6.14 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The business's 50-day moving average price is $139.64 and its 200 day moving average price is $138.18. Agilent Technologies, Inc. has a 12 month low of $104.09 and a 12 month high of $155.35.
Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. The company had revenue of $1.58 billion for the quarter, compared to analysts' expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business's quarterly revenue was down 5.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.43 earnings per share. Analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were issued a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.69%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies's payout ratio is presently 19.50%.
Insider Activity at Agilent Technologies
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock worth $1,739,510 over the last ninety days.
Analysts Set New Price Targets
A has been the subject of a number of research analyst reports. Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a research report on Tuesday, August 27th. They set an "overweight" rating and a $157.00 price objective for the company. Stifel Nicolaus reaffirmed a "buy" rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Bank of America lifted their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a "neutral" rating in a research report on Thursday, August 22nd. Citigroup boosted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a "buy" rating in a research report on Thursday, August 22nd. Finally, UBS Group boosted their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a "neutral" rating in a research report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $144.36.
Read Our Latest Research Report on A
Agilent Technologies Company Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Recommended Stories
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
